Literature DB >> 8427762

Smooth muscle cells and the pathogenesis of the lesions of atherosclerosis.

E W Raines1, R Ross.   

Abstract

In this review we have tried to identify the characteristic features of SMCs in developing lesions of atherosclerosis and the extracellular factors that may be involved in regulating these altered features. Though the list seems long and complex there is probably a great deal of interplay among the different regulatory mechanisms. The function and activities of SMCs in the artery are dependent on the milieu created by the surrounding cells and the components of the extracellular matrix. In the normal, uninjured media of the artery, SMC phenotype and function seem to be in large part determined by the extracellular matrix in which they are embedded and by diffusible factors, in particular from endothelial cells. Endothelial cell injury, infiltration of monocytes and lymphocytes, and ultimately, thrombosis and platelet release, as seen in developing lesions of atherosclerosis, dramatically alter the balance of growth-regulatory and vasoactive factors present in the local environment. These extracellular factors (table and figure) can alter both SMC phenotype, and thus responsiveness, and SMC migration, proliferation, and synthesis of the extracellular matrix. A better understanding of how specific factors mediate these responses, should make it possible to determine the ways in which the SMC response can be modulated. Though growth regulatory molecules seem to be key to this process, the challenge for the future is to understand their regulation in the environment of the artery wall and the interplay between growth-regulatory molecules, extracellular matrix, and vasoactive agents.

Entities:  

Mesh:

Year:  1993        PMID: 8427762      PMCID: PMC1025256          DOI: 10.1136/hrt.69.1_suppl.s30

Source DB:  PubMed          Journal:  Br Heart J        ISSN: 0007-0769


  24 in total

Review 1.  Regulatory functions of the vascular endothelium.

Authors:  J R Vane; E E Anggård; R M Botting
Journal:  N Engl J Med       Date:  1990-07-05       Impact factor: 91.245

Review 2.  Eicosanoids in regulation of arterial smooth muscle cell phenotype, proliferative capacity, and cholesterol metabolism.

Authors:  K B Pomerantz; D P Hajjar
Journal:  Arteriosclerosis       Date:  1989 Jul-Aug

Review 3.  Cell biology of arterial proteoglycans.

Authors:  T N Wight
Journal:  Arteriosclerosis       Date:  1989 Jan-Feb

4.  Inhibitors of angiotensin-converting enzyme prevent myointimal proliferation after vascular injury.

Authors:  J S Powell; J P Clozel; R K Müller; H Kuhn; F Hefti; M Hosang; H R Baumgartner
Journal:  Science       Date:  1989-07-14       Impact factor: 47.728

5.  Cell proliferation in human coronary arteries.

Authors:  D Gordon; M A Reidy; E P Benditt; S M Schwartz
Journal:  Proc Natl Acad Sci U S A       Date:  1990-06       Impact factor: 11.205

6.  Significance of quiescent smooth muscle migration in the injured rat carotid artery.

Authors:  A W Clowes; S M Schwartz
Journal:  Circ Res       Date:  1985-01       Impact factor: 17.367

7.  Heterologous desensitization of platelet-derived growth factor-mediated arachidonic acid release and prostaglandin synthesis.

Authors:  J Domin; E Rozengurt
Journal:  J Biol Chem       Date:  1992-07-25       Impact factor: 5.157

Review 8.  Syndromes of accelerated atherosclerosis: role of vascular injury and smooth muscle cell proliferation.

Authors:  J H Ip; V Fuster; L Badimon; J Badimon; M B Taubman; J H Chesebro
Journal:  J Am Coll Cardiol       Date:  1990-06       Impact factor: 24.094

9.  Localization of PDGF-B protein in macrophages in all phases of atherogenesis.

Authors:  R Ross; J Masuda; E W Raines; A M Gown; S Katsuda; M Sasahara; L T Malden; H Masuko; H Sato
Journal:  Science       Date:  1990-05-25       Impact factor: 47.728

Review 10.  The pathogenesis of atherosclerosis: atherogenesis and inflammation.

Authors:  J M Munro; R S Cotran
Journal:  Lab Invest       Date:  1988-03       Impact factor: 5.662

View more
  56 in total

1.  Blockade of platelet-derived growth factor or its receptors transiently delays but does not prevent fibrous cap formation in ApoE null mice.

Authors:  Koichi Kozaki; Wolfgang E Kaminski; Jingjing Tang; Stan Hollenbach; Per Lindahl; Carol Sullivan; Jin-Chen Yu; Keith Abe; Paul J Martin; Russell Ross; Christer Betsholtz; Neill A Giese; Elaine W Raines
Journal:  Am J Pathol       Date:  2002-10       Impact factor: 4.307

2.  Herbal formula HMC05 prevents human aortic smooth muscle cell migration and proliferation by inhibiting the ERK1/2 MAPK signaling cascade.

Authors:  Yun Hwan Kang; In Jun Yang; Heung Mook Shin
Journal:  J Nat Med       Date:  2011-08-11       Impact factor: 2.343

Review 3.  Novel paradigms for dialysis vascular access: downstream vascular biology--is there a final common pathway?

Authors:  Timmy Lee
Journal:  Clin J Am Soc Nephrol       Date:  2013-08-29       Impact factor: 8.237

4.  Differential regulation of extracellular signal-regulated protein kinases (ERKs) 1 and 2 by cAMP and dissociation of ERK inhibition from anti-mitogenic effects in rabbit vascular smooth muscle cells.

Authors:  R Cospedal; M Lobo; I Zachary
Journal:  Biochem J       Date:  1999-09-01       Impact factor: 3.857

5.  Parallel regulation of arginine transport and nitric oxide synthesis by angiotensin II in vascular smooth muscle cells role of protein kinase C.

Authors:  M Rivera-Correa; P I Altieri; N Escobales
Journal:  Amino Acids       Date:  1996-06       Impact factor: 3.520

6.  Noninvasive localization of human atherosclerotic lesions with indium 111-labeled monoclonal Z2D3 antibody specific for proliferating smooth muscle cells.

Authors:  I Carrió; P L Pieri; J Narula; L Prat; P Riva; L Pedrini; E Pretolani; G Caruso; G Sarti; M Estorch; L Berná; V Riambau; X Matías-Guiu; C Pak; C Ditlow; F Chen; B A Khaw
Journal:  J Nucl Cardiol       Date:  1998 Nov-Dec       Impact factor: 5.952

Review 7.  Chronic rejection. A general overview of histopathology and pathophysiology with emphasis on liver, heart and intestinal allografts.

Authors:  A J Demetris; N Murase; R G Lee; P Randhawa; A Zeevi; S Pham; R Duquesnoy; J J Fung; T E Starzl
Journal:  Ann Transplant       Date:  1997       Impact factor: 1.530

8.  Estradiol attenuates directed migration of vascular smooth muscle cells in vitro.

Authors:  F D Kolodgie; A Jacob; P S Wilson; G C Carlson; A Farb; A Verma; R Virmani
Journal:  Am J Pathol       Date:  1996-03       Impact factor: 4.307

Review 9.  Immunological aspects of atherosclerosis.

Authors:  S Garrido-Urbani; M Meguenani; F Montecucco; B A Imhof
Journal:  Semin Immunopathol       Date:  2013-11-09       Impact factor: 9.623

Review 10.  Adipocytokines in atherothrombosis: focus on platelets and vascular smooth muscle cells.

Authors:  Giovanni Anfossi; Isabella Russo; Gabriella Doronzo; Alice Pomero; Mariella Trovati
Journal:  Mediators Inflamm       Date:  2010-06-28       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.